Home > Resources > Company Profiles > deCODE Genetics Inc. > News

deCODE Genetics Inc. (DCGN)

EMAIL
PRINT
SHARE
TEXT SIZE:
SHARE
Send a copy to me

Separate multiple email addresses (max 20) with commas.

0/1500
Dr. Kari Stefansson, M.D. , Founder/CEO/Chairman of the Board/President/Director
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME


Overview
News
People
Financials

Company Information

Dr. Kari Stefansson, M.D., Founder/CEO/Chairman of the Board/President/Director

Sturlugata 8

IS-101

Reykjavik,

IC Map it

Phone: (354) 570-1900

Fax: (354) 570-1903

www.decode.com



Overview

A biopharmaceutical company applying its discoveries in human genetics to develop drugs and diagnostics for common diseases.

Employees

Number of Employees: 431
Revenue per Employee: $89,769

Top Executives

Dr. Daniel Hartman, M.D., Divisional Senior VP
Lance Thibault, CPA, CFO/Treasurer
Dr. Mark Gurney, Ph.D, Divisional Senior VP

Jakob Sigurdsson, Senior VP, Divisional
Axel Nielsen, COO

Board of Directors

James Beery, Director
Lance Thibault, CPA, CFO/Treasurer
J. Neal Armstrong, Director

Terrance G. McGuire, Vice Chairman/Director
Birgit Stattin Norinder, Director

Financials

Quarterly
Annual

Income Statement 09/2008 05/2008 03/2008 12/2007
Sales 11.14 Mil. 11.73 Mil. 12.54 Mil. 9.64 Mil.
Gross Operating Profit 3.89 Mil. 3.25 Mil. 799 K. 1.25 Mil.
Operating Income before D & A (EBITDA) -11.22 Mil. -16.61 Mil. -19.5 Mil. -19.88 Mil.
Total Income Before Interest Expenses (EBIT) -14.23 Mil. -22.64 Mil. -28.27 Mil. -20.23 Mil.
Total Net Income -18.35 Mil. -26.66 Mil. -32.42 Mil. -24.25 Mil.
Basic EPS, Total -0.3 -0.44 -0.54 -0.4
Diluted EPS, Total -0.3 -0.44 -0.54 -0.4

BALANCE STATEMENT 09/2008 05/2008 03/2008 12/2007
Cash and Equivalents 18.24 Mil. 42.73 Mil. 54.17 Mil. 45.84 Mil.
Total Assets 44.31 Mil. 65.19 Mil. 82.65 Mil. 137.08 Mil.
Total Liabilities 30.28 Mil. 36.14 Mil. 34.26 Mil. 32.44 Mil.
Total Capitalization 26.72 Mil. 66.92 Mil. 65.61 Mil. 120.2 Mil.

Cash Flow 09/2008 05/2008 03/2008 12/2007
Net Cash From Continuing Operations -37.98 Mil. -20.03 Mil. -63.89 Mil. -49.61 Mil.
Net Cash From Investing Activities 3.73 Mil. 9.29 Mil. 78.53 Mil. 55.02 Mil.
Net Cash From Financing Activities -1.68 Mil. -704 K. 17.65 Mil. 18.55 Mil.
Net Change in Cash & Cash Equivalents -35.93 Mil. -11.44 Mil. 32.29 Mil. 23.96 Mil.

powered by Interactive Data

Income Statement 2008 2007 2006 2005
Sales 37.01 Mil. 36.03 Mil. 30.1 Mil. 28.4 Mil.
Gross Operating Profit 3.39 Mil. 4.48 Mil. 13.86 Mil. 13.73 Mil.
Operating Income before D & A (EBITDA) -77.57 Mil. -77.84 Mil. -50.01 Mil. -31.4 Mil.
Total Income Before Interest Expenses (EBIT) -79.88 Mil. -77.66 Mil. -55.27 Mil. -48.27 Mil.
Total Net Income -95.53 Mil. -85.47 Mil. -62.75 Mil. -57.26 Mil.
Basic EPS, Total -1.57 -1.49 -1.17 -1.07
Diluted EPS, Total -1.57 -1.49 -1.17 -1.07

BALANCE STATEMENT 2008 2007 2006 2005
Cash and Equivalents 54.17 Mil. 21.88 Mil. 65.94 Mil. 70.24 Mil.
Total Assets 82.65 Mil. 169.71 Mil. 166.95 Mil. 203.08 Mil.
Total Liabilities 34.26 Mil. 23.5 Mil. 25.52 Mil. 37.91 Mil.
Total Capitalization 65.61 Mil. 156.68 Mil. 146.32 Mil. 241.93 Mil.

Cash Flow 2008 2007 2006 2005
Net Cash From Continuing Operations -63.89 Mil. -85.17 Mil. -54.03 Mil. -29.94 Mil.
Net Cash From Investing Activities 78.53 Mil. -44.42 Mil. 95.83 Mil. -124.65 Mil.
Net Cash From Financing Activities 17.65 Mil. 85.53 Mil. -46.09 Mil. 156.16 Mil.
Net Change in Cash & Cash Equivalents 32.29 Mil. -44.06 Mil. -4.3 Mil. 1.57 Mil.

powered by Interactive Data







News Volume

31 days volume

100%
80%
60%
40%
20%
0
November
December

Company Profile Change Request

The data provided in our company profiles comes from third party information providers.

Also in Portfolio.com
Most Read
Most Emailed
Recently Commented